INFI – Unusual Volume Activity on Thursday Watch List
On 14 March 2019, Shares of Infinity Pharmaceuticals, Inc. (INFI) were valued at $1.91 and moved 24.03%. A total volume of 1.5 million shares were traded unusually versus to average volume of 0.27 million shares. Unusual volume shows something has likely happened in the stock–such as a news release or traders have become worried or euphoric about the stock’s potential. A volume “spike” where volume is way more than normal–5 to 10 times (or more) average volume (for that time or period) for example–could indicate the end of a trend. ue is no one left to keep pushing the price in the trending direction and it reverses (often quickly).
52 week High and Low
Infinity Pharmaceuticals, Inc. (INFI) shares have been seen trading -34.59% off its 52 week- peak value and changed 91.00% from its 52 week-bottom price value. The “percentage off the 52-week high or low” refers to when a stock current price is relative to where it has traded over the last 52 weeks. This gives investors an idea of how much the security has moved in the last year and whether it is trading near the top, middle or bottom of the range.
Infinity Pharmaceuticals, Inc. (INFI) held 58.73 million outstanding shares currently. The company have shares float of 55.24 million. Now have a look at past performance (weekly performance to year to date performance) how Infinity Pharmaceuticals, Inc. (INFI) has been moved; whether it performed well or not. INFI reported a change of 23.23% over the last week and performed 48.06% over the last month while its year to date (YTD) performance revealed an activity trend of 61.86%. The stock’s quarterly performance specifies a shift of 50.39%, and its last twelve month performance is stands at -22.67% while moved -15.49% for the past six months.
Relative Strength Index (RSI)
Infinity Pharmaceuticals, Inc. (INFI)’s Relative Strength Index (RSI) is 69.59. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. Technical analysts have little regard for the value of a company. They use historic price data to observe stock price patterns to predict the direction of that price going forward. Analysts use common formulas and ratios to accomplish this. The Relative Strength Index (RSI), developed by J. Welles Wilder, is a momentum oscillator that measures the speed and change of price movements. The RSI oscillates between 0 and 100. A value between 0 and 30 is considered oversold; hence the trader should look at buying opportunities. A value between 70 and 100 is considered overbought; hence the trader should look at selling opportunities.
Average True Range (14) for Infinity Pharmaceuticals, Inc. (INFI) is stands at 0.15. ATR is a volatility indicator. Volatility measures the strength of the price action, and is often overlooked for clues on market direction..
Over the past week, the company showed volatility of 15.06%. Moving out to look at the previous month volatility move, the stock is at 10.69%. A stock with a price that fluctuates wildly, hits new highs and lows or moves erratically is considered highly volatile.
Beta measures volatility or systematic risk, of a stock or a portfolio in comparison to the market as a whole. 1 shows stock moves with market. < 1 means less volatile than market. > 1 indicates more volatile than the market. The stock’s beta is 2.18.
Analyst mean recommendation rating on a stock by the analyst community is at 3.00. Analyst rating score as published on FINVIZ are rated on a 1 to 5 scale. 1 is equivalent to a buy rating, 3 a hold rating, and 5 a sell rating.